NCT07351916Recruiting
Remission in Adults With Mild-to-moderate Asthma in Thailand
Source: ClinicalTrials.gov · Last updated 17 Apr 2026
Brief summary (registry, in English)
The goal of this observational study is to determine the prevalence of remission among adults with mild-to-moderate asthma, as well as the factors associated with remission in Thailand. The main question the study aims to answer is: What is the prevalence of remission among adults with severe asthma in Thailand? Participants will complete a questionnaire on asthma symptoms and undergo pulmonary function testing and a blood test once.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 289 (estimated)
- First submitted
- 10 Jan 2026
- Start date
- 1 Feb 2026
- Primary completion date
- 31 Oct 2026
- Lead sponsor
- Thammasat University
- Diseases
- Asthma
- NCT number
- NCT07351916
What you commit to
- Study type: Observational
- Planned participants: 289
- From 1 Feb 2026 to the primary completion date, 31 Oct 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- inability to perform spirometry or fractional exhaled nitric oxide (FeNO) test
Who the study is looking for
- mild-to-moderate asthma
- age 18 years or older
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Medicine, Thammasat University Coordinator of this site? Confirm its status | Pathum Thani | Thailand | Recruiting |
| Narongkorn Saiphoklang Coordinator of this site? Confirm its status | Pathum Thani | Thailand | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.